Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)-Reference-Cited by-同舟云学术

Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)

Published:2012-02 Issue:2-3 Volume:134 Page:187-194
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Grimaldi-Bensouda Lamiae,Rouillon Frederic,Astruc Bernard,Rossignol Michel,Benichou Jacques,Falissard Bruno,Limosin Frederic,Beaufils Beatrice,Vaiva Guillaume,Verdoux Helene,Moride Yola,Fabre Alban,Thibaut Florence,Abenhaim Lucien

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference27 articles.

1. Diagnostic and statistical manual of mental disorders: DSM-IV-TR;American Psychiatric Association,2000

2. Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study;Bai;J. Clin. Psychiatry,2007

3. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets;Chue;Eur. Neuropsychopharmacol.,2005

4. Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study;De la Gándara;Expert Rev. Neurother.,2009

5. Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia;Di Lorenzo;Neuropsychiatr. Dis. Treat.,2010

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder;Psychiatry Research;2024-02

2. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024

3. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2023

4. Efficacy, Tolerability, and Acceptance of Long-Lasting Antipsychotics in Children and Adolescents: A Systematic Review;Journal of Child and Adolescent Psychopharmacology;2022-08-01

5. Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics;BMC Psychiatry;2022-03-17